Scientists identify target to treat COVID pneumonia and reduce severity
Clinical trials with new experimental drug to begin early in 2021
Goal is to develop treatments that make COVID-19 no worse than a common cold
First comparison between immune mechanisms driving COVID-19 pneumonia with other pneumonias
CHICAGO - Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung over the course of hours. In the modern intensive care unit, these bacteria or viruses are usually controlled either by antibiotics or by the body s immune system within the first few days of the illness.
But in a study published in